COHANCE / NSE / Biotechnology & Drugs
Cohance Lifesciences
1Y Price Trend
Key Information
Recommendations
RatingHold
Target High1,121.15
Target Low267.85
Target Mean3.25
Target Median81.25
Risk Metrics
Overall RiskHigh risk
Board Risk56.66
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Cohance Lifesciences - 10 Nifty 500 stocks plunge over 50% from 52-week highs. Do you own any? The Economic Times
Cohance Lifesciences (COHANCE) Q2 25/26 earnings summary Quartr
COHANCE LIFESCIENCES LTD Share Price Today - Live COHANCE Stock Price for NSE/BSE Upstox
Cohance Lifesciences promoter declares no encumbrance on shares scanx.trade
Umang Vohra Appointed Executive Chairman and Group CEO of Cohance Lifesciences Machine Maker
Cohance seeks govt approval for Umang Vohra as Chairman scanx.trade
Stock FAQs
What is the symbol and ISIN of Cohance Lifesciences?
Cohance Lifesciences has the symbol COHANCE and ISIN - INE03QK01018.
What is the current price of Cohance Lifesciences?
Cohance Lifesciences is currently trading at INR 451.90.
What are the year high and year low of Cohance Lifesciences?
Cohance Lifesciences has a year high of INR 1,121.15 and a year low of INR 267.85.
What is the market capitalization of Cohance Lifesciences?
Cohance Lifesciences has a market capitalization of INR 17,265.35 crore.
What is the P/E ratio of Cohance Lifesciences?
Cohance Lifesciences has a P/E ratio of 64.28.
What is the dividend yield of Cohance Lifesciences?
Cohance Lifesciences has a dividend yield of 0.00%.
How is the financial performance of Cohance Lifesciences based on revenue, net income, and EPS?
Cohance Lifesciences has revenue of INR 22,685.50 crore, net income of INR 1,792.30 crore, and EPS of INR 5.08.
What is the book value of Cohance Lifesciences?
Cohance Lifesciences has a book value of INR 66.08.
What is the debt-to-equity ratio of Cohance Lifesciences?
Cohance Lifesciences has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Cohance Lifesciences?
Cohance Lifesciences has a price-to-book ratio of 6.84 and a price-to-sales ratio of 0.76.
© SharekeyX | Rusaka Technologies 2024-2026